Leong Justin 4
4 · RESMED INC · Filed Nov 23, 2022
Insider Transaction Report
Form 4
RESMED INCRMD
Leong Justin
Chief Product Officer
Transactions
- Exercise/Conversion
ResMed Common Stock Options
2022-11-22−15,000→ 0 totalExercise: $57.76From: 2017-11-16Exp: 2023-11-16→ ResMed Common Stock (15,000 underlying) - Exercise/Conversion
ReMed Common Stock
2022-11-22$57.76/sh+15,000$866,400→ 63,594 total - Sale
ReMed Common Stock
2022-11-22$229.50/sh−3,777$866,820→ 59,817 total - Award
ReMed Common Stock
2022-11-23+6,924→ 66,741 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price.
- [F2]Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.